Hims & Hers Health, Inc.·4

Jan 21, 4:23 PM ET

Okupe Oluyemi 4

Research Summary

AI-generated summary

Updated

Hims & Hers CFO Okupe Oluyemi Exercises Options, Sells 9,067 Shares

What Happened
Okupe Oluyemi, CFO of Hims & Hers (HIMS), exercised stock options on January 20, 2026 to acquire a total of 9,067 shares (7,317 at $5.01 and 1,750 at $11.53) for a cash cost of $56,836. On the same day he sold those 9,067 shares in an open‑market transaction for an aggregate reported proceeds of $275,114 (weighted average price $30.34). The filings include the option exercise records (coded M) and the open‑market sale (coded S).

Key Details

  • Transaction date: January 20, 2026; Form 4 filed January 21, 2026 (timely).
  • Options exercised: 7,317 shares at $5.01 ($36,658) and 1,750 shares at $11.53 ($20,178).
  • Shares sold: 9,067 shares in the open market for total proceeds of $275,114; weighted average sale price $30.34 (range $30.21–$30.44).
  • The $0.00 "disposed" entries reflect conversion of the derivative/options into shares as part of the exercise reporting.
  • Plan note: Transactions were effected under a Rule 10b5‑1 trading plan adopted May 21, 2025 (footnote F1). Vesting schedules for the options are described in the filing (monthly vesting over four years; see F3/F4).
  • Shares owned after the reported transactions: not disclosed in this Form 4.

Context

  • This sequence (exercise of options followed by immediate sale of the acquired shares) is a common liquidity action and is often executed under pre‑arranged 10b5‑1 plans; it does not by itself indicate management sentiment about the company’s prospects.
  • For clarity: M = option exercise/conversion, S = open‑market sale. The weighted average sale price and the plan disclosure mean the sale likely followed pre‑set instructions rather than ad‑hoc trading.